Products
16169 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 5.942 | 0.054 | 0.003 | 0.057 | 1 | -5.26% | -5.26% | -39.33% | 30 Nov. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 125.746 | 68.13 | 1.290 | 69.42 | 1 | -1.86% | 49.57% | 100.50% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 125.746 | 20.93 | 0.180 | 21.11 | 1 | -0.85% | 14.81% | 30.32% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 125.746 | 3.62 | 0.070 | 3.69 | 1 | -1.90% | 39.77% | 81.00% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 125.746 | 17.73 | 0.190 | 17.92 | 1 | -1.06% | 22.95% | 46.89% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 125.746 | 10.12 | 0.160 | 10.28 | 1 | -1.56% | 31.09% | 64.02% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 125.746 | 0.12 | 0.030 | 0.15 | 1 | -20.00% | -36.84% | -47.83% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 125.746 | 0.72 | 0.030 | 0.75 | 1 | -4.00% | -17.24% | -30.10% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 125.746 | 0.031 | ― | ― | 1 | 0.00% | -32.61% | -59.21% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 125.746 | 0.089 | 0.003 | 0.092 | 1 | -3.26% | -40.67% | -55.50% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 125.746 | 0.024 | 0.003 | 0.027 | 1 | -11.11% | -27.27% | -42.86% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 311.441 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -99.71% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 311.441 | 0.02 | 0.003 | 0.023 | 1 | -13.04% | 0.00% | -99.67% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 311.441 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 311.441 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 311.441 | 2.61 | 0.030 | 2.64 | 1 | -1.14% | 10.59% | -75.35% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 311.441 | 3.42 | 0.040 | 3.46 | 1 | -1.16% | -17.79% | 24.36% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 311.441 | 0.11 | 0.030 | 0.14 | 1 | -21.43% | -38.89% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 311.441 | 0.007 | 0.002 | 0.009 | 1 | -22.22% | -22.22% | -36.36% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1246615640 | Nvidia | Constant Leverage | Long | ― | 182.739 | 0.27 | 0.010 | 0.28 | 1 | -3.57% | -15.63% | -27.03% | 8 Jun. 2023 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.